MedPath

ECigs, Inflammation and Oxidative Stress

Not Applicable
Completed
Conditions
E-cigarettes, Oxidative Stress, Inflammation
Registration Number
NCT03823885
Lead Sponsor
University of California, Los Angeles
Brief Summary

Randomized controlled trial of acute use of electronic cigarette effect on oxidative stress and inflammation.

Detailed Description

Participants will have an acute e-cig exposure on 2 occasions 1) e-cigarette 2) sham e-cig (empty e-cig) control. Blood will be collected before and after E-cig use and analyzed for biomarkers of inflammation and oxidative stress.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
148
Inclusion Criteria
  • Healthy
Exclusion Criteria
  • Cardiac disease Respiratory disease Diabetes

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Cellular Reactive Oxygen Species, units = % fluorescencewithin 4 hours of E-cig use

cellular oxidative stress, including cytoplasmic and mitochondrial oxidative stress, in viable cells

Secondary Outcome Measures
NameTimeMethod
CD 14+ Monocyte, units = % of total cellswithin 4 hours of e-cig use

CD 14+ Monocyte, % of total cells will be measured with antibodies and stable dye

Trial Locations

Locations (1)

UCLA

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

UCLA
πŸ‡ΊπŸ‡ΈLos Angeles, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.